Wooridul Huebrain Limited

KSE 118000.KS

Wooridul Huebrain Limited EBT Margin for the year ending December 31, 2023: -46.95%

Wooridul Huebrain Limited EBT Margin is -46.95% for the year ending December 31, 2023, a 81.91% change year over year. EBT Ratio (Earnings Before Tax Ratio) is the fraction of earnings before taxes to total revenue, indicating the company's profitability before the impact of tax expenses.

Wooridul Huebrain Limited EBT Margin for the year ending December 31, 2022 was -259.47%, a -744.23% change year over year.
Wooridul Huebrain Limited EBT Margin for the year ending December 31, 2021 was 40.28%, a -12.00% change year over year.
Wooridul Huebrain Limited EBT Margin for the year ending December 31, 2020 was 45.77%, a 766.92% change year over year.
Wooridul Huebrain Limited EBT Margin for the year ending December 31, 2019 was -6.86%, a 79.78% change year over year.

Key data

Date	EBT Margin	Net Income Margin	EBITDA Margin	EBIT Margin

KSE: 118000.KS

Wooridul Huebrain Limited

CEO	Ms. Soo-Kyung Kim
IPO Date	May 5, 2006
Location	South Korea
Headquarters	156, No. 202, Dream Building)
Employees	23
Sector	Healthcare
Industries Drugstores & Retail Pharmacies Biotechnology Cosmetics Dental Care Hardware & Electronics Medical Instruments Personal Care Pharmaceuticals

Description

Wooridul Huebrain Limited engages in the medical, life and health, pharmaceutical, and storage businesses. It sells medical equipment and appliances, health equipment, medicines, and computer servers. Wooridul Huebrain Limited was formerly known as Wooridul Life Sciences Limited and changed its name to Wooridul Huebrain Limited in April 2014. Wooridul Huebrain Limited was founded in 2009 and is based in Seoul, South Korea.

Key trends

Past 5 years